Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Documenti analoghi

• Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.
  di: Noseworthy, J H, et al.
  Pubblicazione: (1994)
• Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis
  di: Rodriguez, Moses
  Pubblicazione: (2007)
• Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler’s Virus-Induced Demyelinating Disease
  di: McCarthy, Derrick P., et al.
  Pubblicazione: (2012)
• Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination
  di: Pavelko, Kevin D., et al.
  Pubblicazione: (1998)
• Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.
  di: Rodriguez, M, et al.
  Pubblicazione: (1995)